InnoCan Pharma Corporation (CSE: INNO)
Canada
· Delayed Price · Currency is CAD 0.235
+0.025 (11.90%)
Nov 21, 2024, 11:31 AM EST
InnoCan Pharma Revenue
InnoCan Pharma had revenue of $8.64M USD in the quarter ending June 30, 2024, with 176.96% growth. This brings the company's revenue in the last twelve months to $24.39M, up 271.49% year-over-year. In the year 2023, InnoCan Pharma had annual revenue of $13.66M with 433.69% growth.
Revenue (ttm)
$24.39M
Revenue Growth
+271.49%
P/S Ratio
1.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.26M CAD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.51B |
| Trulieve Cannabis Corp. | 1.58B |
| Cresco Labs Inc. | 981.27M |
| Grown Rogue International Inc. | 28.83M |
| Planet 13 Holdings Inc. | 147.38M |
| Ayr Wellness Inc. | 627.53M |
| Jushi Holdings Inc. | 350.48M |
| MariMed Inc. | 213.26M |